期刊
ONCOIMMUNOLOGY
卷 2, 期 1, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.22059
关键词
adoptive T cell therapy; cyclophosphamide; immunostimulatory chemotherapy; melanoma; tumor escape
资金
- NATIONAL CANCER INSTITUTE [R01CA107082] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA107082] Funding Source: Medline
Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell populations and immunostimulatory chemotherapy can enhance long-term survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据